コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 re filled during the postoperative period of cataract surgery.
2 tandard indications of combined glaucoma and cataract surgery.
3 ify dementia patients likely to benefit from cataract surgery.
4 and result in refractive surprise following cataract surgery.
5 intraocular lenses (IOLs) currently used in cataract surgery.
6 oma is a common complication after pediatric cataract surgery.
7 the use of toric IOLs in patients undergoing cataract surgery.
8 predictive value for DED symptom onset after cataract surgery.
9 with a history of previous PRK or LASIK and cataract surgery.
10 f IOL (SN60WF) following phacoemulsification cataract surgery.
11 ely to achieve sustained IOP reduction after cataract surgery.
12 ative refractive errors (RE) one month after cataract surgery.
13 doexfoliation (PEX) 5 years after undergoing cataract surgery.
14 tline an optimal postoperative regimen after cataract surgery.
15 at the beginning of planned glaucoma and/or cataract surgery.
16 another intraocular surgery, and complicated cataract surgery.
17 d either multifocal or monofocal IOLs during cataract surgery.
18 case volume and visual acuity outcomes after cataract surgery.
19 portant risk factor for complications during cataract surgery.
20 ge number of people in society with previous cataract surgery.
21 sion, corneal transplantation, glaucoma, and cataract surgery.
22 complications or worse visual outcomes after cataract surgery.
23 n the appropriate subgroup of patients after cataract surgery.
24 invaluable when counseling patients prior to cataract surgery.
25 ikely to have significant visual gains after cataract surgery.
26 ons and risk factors for, IOL exchange after cataract surgery.
27 s were evaluated before and for 1 year after cataract surgery.
28 ystems in the context of subjects undergoing cataract surgery.
29 The most common clinical setting was post-cataract surgery.
30 diagnosis of macular edema within 90 days of cataract surgery.
31 KA) between 0.75 and 2.5 diopters (D) during cataract surgery.
32 ular and long-term follow-up after pediatric cataract surgery.
33 ar edema is common after phacoemulsification cataract surgery.
34 that can occur after otherwise uncomplicated cataract surgery.
35 quantifying spectacle independence following cataract surgery.
36 e assessing spectacle independence following cataract surgery.
37 on practice in children undergoing pediatric cataract surgery.
38 ased significantly after phacoemulsification cataract surgery.
39 lens complications are uncommon with modern cataract surgery.
40 ulators and their use in lens prediction for cataract surgery.
41 on or prior to each beneficiary's first-eye cataract surgery.
42 ffer treatment of astigmatism at the time of cataract surgery.
43 pe 2) did not influence the rate of post-PPV cataract surgery.
44 tious endophthalmitis, 74% were unrelated to cataract surgery.
45 t fall short of benchmarks for uncomplicated cataract surgery.
46 ON within 2 months and AION within 1 year of cataract surgery.
47 receiving a SAP by cefuroxime at the end of cataract surgery.
48 and falls in Medicare beneficiaries awaiting cataract surgery.
49 .5 months (range, 1-7 months) at the time of cataract surgery.
50 compared to unilateral and 2-timed bilateral cataract surgery.
51 halmology, with a positive impact far beyond cataract surgery.
52 ransplantation, 4 patients (6 eyes) required cataract surgery.
53 refractive surprise in a patient undergoing cataract surgery.
54 clear corneal sutureless phacoemulsification cataract surgery.
55 ic examinations for first eye and second eye cataract surgeries.
56 ophthalmic procedures) than after standalone cataract surgeries (0.20% vs. 0.04% of cases), and occur
57 rcept (1.93), preoperative AL (0.91), age at cataract surgery (-0.07), age at follow-up (0.14), and i
61 ity ratio vs. no therapy that is superior to cataract surgery ($2,262/QALY), amblyopia therapy ($2,71
62 001), perimetry (85.3% vs 79.8%; P < .0001), cataract surgery (23.4% vs 12.3%; P < .0001), laser trab
64 office visits (mean, 9.1 vs 7.9; P = .001), cataract surgery (34.9% vs 19.0%; P < .0001), and glauco
72 in at least 1 eye (aDelta: 5.50, P < 0.001), cataract surgery (aDelta: 3.01, P = 0.017), and quieting
73 OL exchange/removal: an adverse event during cataract surgery (adjusted odds ratio [aOR] 19.45; 95% C
76 aigis-L formula prediction errors in routine cataract surgery after refractive surgery for myopic cor
77 veitis (aHR, 0.75; 95% CI, 0.59-0.96), prior cataract surgery (aHR, 0.70; 95% CI 0.56-0.88), and glau
79 acuity of <20/60 compared to those that had cataract surgery alone (adjusted RR 2.60 95% CI, 1.13-6.
82 ct implantation with cataract surgery versus cataract surgery alone, with excellent safety through 2
87 te 5-year incidences were determined for all cataract surgeries and specifically for standalone proce
89 ptomatic patients who have had uncomplicated cataract surgery and a routine postoperative day 1 exami
93 m were studied before and after simultaneous cataract surgery and LRIs (at weeks 1, 4 and 12), patien
94 TMB (iStent Inject; Glaukos Corporation) and cataract surgery and one normal patient undergoing catar
95 Eighty patients (160 eyes) had bilateral cataract surgery and received a Vivinex XY1 IOL in 1 eye
96 ield macular thickness) within 90 days after cataract surgery and the patients (%) with a best-correc
97 nges in visual acuity [VA], activity status, cataract surgery) and systemic events (e.g., infections
98 s (12.4%) returned to the operating room for cataract surgery, and 643 eyes (3.7%) returned to the op
99 d for age, sex, AMD severity, VA, history of cataract surgery, and assigned AREDS2 study treatment.
100 age-related macular degeneration, performed cataract surgery, and at least 10 intravitreal (excludin
102 re PCG, glaucoma after congenital idiopathic cataract surgery, and glaucoma associated with trauma.
103 older age, non-white race, glaucoma surgery, cataract surgery, and moderate baseline VF damage (-6 dB
105 at the postoperative week 1 timepoint after cataract surgery are rare in asymptomatic patients who h
106 a similar risk of endophthalmitis following cataract surgery as the noncancer population, and the cu
107 xial length (AL) from the time of unilateral cataract surgery at age 1 to 7 months to age 5 years, an
109 selection is a major challenge of pediatric cataract surgery attributable to unpredictable future ey
110 ta: -0.07; P < .001) (or lower prevalence of cataract surgery [B: -0.78; 95% CI: -1.44, -0.13; beta:
111 Despite a modest worsening in CRT after cataract surgery, BCVA was improved in both treatment gr
113 children (199 eyes) who underwent pediatric cataract surgery before 1 year of age with a minimum of
114 oorer survival was associated with bilateral cataract surgery before enrollment compared with baselin
115 eyes with keratoconus that had uncomplicated cataract surgery between 2014 and 2018 at a single insti
119 of 25,818 consecutive patients who underwent cataract surgery between the years 2014 and 2018 at Hels
120 of AION is increased in the first year after cataract surgery, but not in the early (i.e., 2 months)
121 in simultaneous bilateral than in unilateral cataract surgery, but only by the surgery time of the se
122 g a multifocal IOL added to the costs of the cataract surgery, but the OCT increased the detection of
126 Seventy eyes of 40 POAG patients undergoing cataract surgery by phacoemulsification were retrospecti
127 d median number of days between biometry and cataract surgery, calculated the proportion of patients
128 ulation, and the current study suggests that cataract surgery can be considered as appropriately indi
129 ases of incorrect implants being used during cataract surgery (cataract extraction and intraocular le
130 istory of autoimmune disease and/or uveitis, cataract surgery combined with another intraocular surge
132 lar Pressure in Glaucoma Patients Undergoing Cataract Surgery (COMPASS) trial who underwent Micro-Ste
133 lar Pressure in Glaucoma Patients Undergoing Cataract Surgery (COMPASS) trial who underwent Micro-Ste
134 include studying treatments and outcomes in cataract surgery, corneal transplantation, and macular d
135 lication rate, poor visual outcomes, and low cataract surgery coverage indicated that actions to impr
139 nges at the postoperative week 1 visit after cataract surgery, defined as an unanticipated change in
142 at cataracts is Delayed Sequential Bilateral Cataract Surgery (DSBCS), during which patients have a s
145 591 733 Medicare beneficiaries who underwent cataract surgery during that calendar year, with brand m
149 ctive outcomes of femtosecond laser assisted cataract surgery (FLACS) using Victus platform (Technola
151 Patients who underwent phacoemulsification cataract surgery from October 2016 to June 2018 in a ter
152 pipeline was used to identify laterality of cataract surgery from operative notes and laterality of
154 e glaucoma (JOAG n = 16), glaucoma following cataract surgery (GFCS n = 15), and other secondary form
155 eitis, younger age, bilateral uveitis, prior cataract surgery, glaucoma surgery, presence of keratic
156 al postoperative data were collected for the cataract surgery group, including preoperative and posto
158 ement of surgical technology and techniques, cataract surgery has evolved to small-incisional surgery
161 ture adult size AL for each child undergoing cataract surgery, helping the surgeon to customize the s
163 drops prescribed for postoperative use after cataract surgery in 2016 was approximately $170 million.
164 oral compared with intravenous sedation for cataract surgery in a diverse patient population in term
166 Follow-up to age 5 years after bilateral cataract surgery in children aged 7 to 24 months reveals
167 RD is estimated for the first 10 years after cataract surgery in children with no known ocular and sy
170 r advances are needed to improve outcomes of cataract surgery in eyes that have undergone corneal ref
171 k of posterior capsular rupture (PCR) during cataract surgery in eyes with previous intravitreal inje
172 mplantation of iris prosthesis combined with cataract surgery in eyes with previous iridocyclectomy f
173 t PPV, we observed a trend for a lower HR of cataract surgery in eyes with proliferative retinopathy
175 long-term, prospective comparative study of cataract surgery in eyes with uncomplicated PEX, the ris
177 atients 66 years of age and older undergoing cataract surgery in Ontario, Canada, between January 1,
179 egrated analysis showing improved BCVA after cataract surgery in patients with diabetic retinopathy,
180 riatics and 1 anesthetic (ICMA, Mydrane) for cataract surgery in patients with well-controlled type-2
181 ation, San Clemente, CA) in combination with cataract surgery in subjects with mild to moderate prima
183 cantly higher than in the reference group of cataract surgery in the anterior chamber angle (16.2 +/-
184 of phakic patients in the PPV arm underwent cataract surgery in the study eye before 12 months versu
185 intervention, including after uncomplicated cataract surgery, increases according to the number of p
190 Posterior capsule opacification (PCO) after cataract surgery is influenced by intraocular lens (IOL)
194 ost common vision-disrupting complication of cataract surgery is posterior capsule opacification (PCO
196 that so far has mostly been implanted during cataract surgery, is a microelectronic sensor that measu
199 whether routine preoperative testing delays cataract surgery long enough to cause clinical harm is u
201 cation and sutureless, manual small-incision cataract surgery (M-SICS), as well as in patients with p
203 Approximately 20.5% of patients undergoing cataract surgery may have macular pathologies, of which
204 ts with postsurgical ME stratified into post-cataract surgery ME (PCSME) and post-other surgery ME (P
205 atient surgical procedures (cholecystectomy, cataract surgery, meniscectomy, muscle/tendon procedures
208 = 37; 31.6%) in April 2020, whereas elective cataract surgery (n = 481; 47.3%) was the most common pr
209 identified, clinical settings included post-cataract surgery (n = 6), post-penetrating keratoplasty
210 validated task-specific assessment tool for cataract surgery (Objective Structured Assessment of Cat
211 lectomy were identified with a median age at cataract surgery of 11 months (7-23); 68% received a pri
213 nts suffer from bilateral cataract and while cataract surgery of only one eye is effective in restori
214 Twenty of 102 (19.6%) patients had previous cataract surgery, of which 2 and 9 developed AION within
215 ients were treated for endophthalmitis after cataract surgery, of which 57 (51%) were culture-positiv
217 of this research is to assess the effect of cataract surgery on the iris texture pattern as a means
219 replacement were compared with eyes that had cataract surgery only (n = 47) across demographic and cl
220 iology of infection, 18 (75%) eyes were post-cataract surgery (operated elsewhere), 3 (12.5%) eyes we
221 eassess the prevalence and incidence of post-cataract surgery optic neuropathy (PCSON) in the modern
224 zed eyes, acute endophthalmitis secondary to cataract surgery or secondary lens implantation represen
225 probability of treatment with LT, including cataract surgery (OR, 0.31; 95% CI, 0.30-0.32), corneal
229 nced a 59% average increase in the number of cataract surgeries per surgeon with 10 hospitals showing
232 dophthalmitis occurred in 0.04% of 8 542 838 cataract surgeries performed in the United States betwee
233 examined in South Indian patients requiring cataract surgery, PEX was associated with higher systoli
235 odds ratios (ORs) for age, gender, previous cataract surgery, previous corneal transplantation, prev
236 Inclusion criteria consisted of unilateral cataract surgery prior to 7 months of age and anterior P
238 mpared with cataract surgery alone, TBS plus cataract surgery showed a 99% probability of being more
242 ed dementia were also less likely to receive cataract surgery than beneficiaries without diagnosed de
243 ecruitment and the date of the occurrence to cataract surgery, the time to the last visit of the foll
244 In a large cohort of patients who underwent cataract surgery, the use of a BLF IOL resulted in no ap
245 cts GmbH) is implanted during small-incision cataract surgery; the latest development is an even smal
246 Among US Medicare beneficiaries undergoing cataract surgery, those with dementia are more likely to
247 gMAR BCVA improved from 0.73 +/- 0.70 before cataract surgery to 0.46 +/- 0.63 (P < .001) after vitre
248 nge in a myopic direction from 1 month after cataract surgery to age 1.5 years was 0.35 diopters (D)/
251 l group were followed for 3 months after the cataract surgery to obtain the rate of endophthalmitis.
252 acameral vancomycin use during an uneventful cataract surgery treated with early anti-VEGF treatment.
254 seudophakic eyes or DMEK in combination with cataract surgery (triple-DMEK) between September 3, 2013
255 s with the outcomes after DMEK combined with cataract surgery (triple-DMEK) in patients with Fuchs' e
256 hieved after iStent inject implantation with cataract surgery versus cataract surgery alone, with exc
260 legal indemnity for incorrect implant during cataract surgery was $57 514 (United States dollars).
261 ression and intervention after uncomplicated cataract surgery was 0%, 50%, and 75% when none, 1 or 2,
262 lative incidence of Nd:YAG capsulotomy after cataract surgery was 13.2% (95% confidence interval [CI]
270 oids among patients undergoing uncomplicated cataract surgery was associated with lower rates of clin
274 ate of endophthalmitis within 3 months after cataract surgery was similar between the 2 study groups:
277 study of mortality in relation to receipt of cataract surgery, we sought to describe those study desi
278 A total of 123 eyes of 80 patients prior to cataract surgery were assigned to 2 groups based on norm
279 ar view and absence of endophthalmitis after cataract surgery were associated with an increased likel
280 ctive study 63 patients undergoing binocular cataract surgery were divided into four groups for impla
282 dophthalmitis occurring within 30 days after cataract surgery were identified using diagnosis codes i
286 patients with POAG, regularly scheduled for cataract surgery, were implanted with a ring-shaped, sul
289 ral cataract and an indication for bilateral cataract surgery with an expected uncomplicated intraope
290 Two hundred forty-three patients underwent cataract surgery with bilateral implantation of the TFNT
291 e study included patients having age-related cataract surgery with implantation of either a plate-hap
292 gible eye from patients having uncomplicated cataract surgery with insertion of an Alcon SN6AT(2-9) I
297 ts were randomized in a 2:1 ratio to undergo cataract surgery with placement of the HMS versus catara
298 0 children (76 eyes) who underwent bilateral cataract surgery with primary posterior capsulectomy wer